NCT02285946

Brief Summary

During mechanical ventilation, the alveolar recruitment maneuver (ARM) is to apply a positive end-expiratory pressure (PEEP) (generally 30 cm H2O) for a period of at least 30 seconds. The realization of MRA is one of three main elements of mechanical ventilation called "protective". This ventilatory strategy, originally described for the ventilation of acute respiratory distress syndrome (ARDS), and pulmonary and during abdominal surgery is based on a decrease tidal volumes, optimization of PEEP and the realization of MRA. Protective ventilation limit the occurrence of atelectasis, the surdistentions and, ultimately, significantly decreases postoperative complications. The MRA is currently recommended in the "major" surgery. Most spine surgery (eg transpedicular fixation) used in this definition, the MRA are indicated and now commonly used. This type of surgery requires further positioning the patient in the prone position (DV). The DV modifies the compliance of the chest respiratory characteristics and changes (increase in insufflation pressure) and hemodynamic (decreased venous return) of the patient. Respiratory and haemodynamic effects of MRA made VIS at major spine surgery are not known. The aim of this observational study, non-interventional, is to compare the hemodynamic and respiratory effects of MRA performed in DV to those of MRA performed in the prone position (DD). The investigators hypothesis is that the respiratory and hemodynamic consequences of MRA performed in DV is different from those conducted in DD. A better understanding of hemodynamic and respiratory characteristics of MRA performed in DV would provide a more tailored to this type of surgery respiratory optimization strategy and reduce respiratory complications of this surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 2, 2014

Completed
1 month until next milestone

Study Start

First participant enrolled

November 1, 2014

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 7, 2014

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

September 5, 2025

Status Verified

September 1, 2025

Enrollment Period

2.8 years

First QC Date

October 2, 2014

Last Update Submit

September 4, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • The hemodynamic and respiratory data are collected before, during and after the completion of 3 ARM (alveolar recruitment maneuver):

    T1: ARM (in a supine position) (before setting prone position); T2: ARM (prone position) ; T3: ARM at acute respiratory distress syndrome [ARDS] (end of intervention, after supine position); (* At the end of ARM, only hemodynamic data are collected)

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient operated major spine surgery, including: * The transpedicular osteotomies * Tumor spinal surgery (sarcoma, osteosarcoma) or metastatic * Degenerative spinal surgery on multiple vertebral levels and degraded land * Surgery of scoliosis * Recovery of spinal surgery on several levels * Sepsis spinal presumed origin

You may qualify if:

  • Adult patient
  • Patient operated major spine surgery, including:
  • The transpedicular osteotomies
  • Tumor spinal surgery (sarcoma, osteosarcoma) or metastatic
  • Degenerative spinal surgery on multiple vertebral levels and degraded land
  • Surgery of scoliosis

You may not qualify if:

  • Inability to give informed patient information (eg difficulty of understanding)
  • Patient under guardianship - Patient pregnant or during lactation - Detainees or under judicial protection.
  • contraindications to MRA: emphysema, pneumothorax, major hypovolemia, hemodynamic instability defined as systolic blood pressure below 90 mmHg or tachycardia greater than 110 bpm.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service D'Anesthesiologie - Nhc

Strasbourg, 67091, France

Location

Study Officials

  • COLLANGE Olivier, MD

    Strasbourg University Hospital, France

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 2, 2014

First Posted

November 7, 2014

Study Start

November 1, 2014

Primary Completion

September 1, 2017

Study Completion

September 1, 2017

Last Updated

September 5, 2025

Record last verified: 2025-09

Locations